Recent Postings to

Worst Pills, Best Pills Newsletter Articles

  View the entire September 2015 issue in PDF format

  • News Brief for September 2015
    (September 2015)
    In our news brief this month, we report on a recent FDA safety warning about permanent disfiguring skin color changes caused by a medication patch used for treating attention-deficit hyperactivity disorder.
  • Selling More Drugs by Misrepresenting Their Safety
    (September 2015)
    Last year, the FDA proposed a guidance that would give drug com¬panies free rein to tell doctors that medications are less dangerous than the FDA has concluded. Find out the serious threat posed by this guidance and action you can take to stop it.
  • Questions & Answers
    (September 2015)
    In response to our recent article on osteoporosis, a reader asks for our opinion regarding the use of the dietary supplement PROSTEON for this disorder. See our independent assessment of this supplement.
  • Warning From FDA on Prescription Drops for Ear Pain
    (September 2015)
    In July, the FDA announced that the agency will be requiring manufacturers to stop selling 16 types of prescription ear drops. These drugs have never been approved as safe and effective for their marketed uses. Find out the names of these drugs so you can protect yourself and your family members from these potentially harmful and unproven remedies.
  • VYVANSE for Binge Eating: Old Pill, New ‘Disease’
    (September 2015)
    Don't fall prey to a drug company's slick marketing campaign of a dangerous drug recently approved by the FDA for treatment of a newly designated disease called "binge eating disorder."
  • FDA Bolsters Warnings About Heart Attack, Stroke Risks for Commonly Used Pain Drugs
    (September 2015)
    Worst Pills, Best Pills News editor Dr. Michael Carome discusses the FDA’s recent safety alert announcing that the agency is strengthening existing warnings in the product labels for all non-aspirin nonsteroidal anti-inflammatory drugs about increased risk of heart attack and stroke.
  • DUAVEE, Hot Flashes and Bone Health
    (September 2015)
    Learn why the new combination of conjugated estrogens plus bazedoxifene (DUAVEE) is a bad choice for treating hot flashes and improving bone health in menopausal women.

  View the entire August 2015 issue in PDF format

  • Pharma Companies Buying Old Drugs, Dramatically Increasing Prices
    (August 2015)
    Learn about one disturbing pharmaceutical industry trend contributing to skyrocketing prices of certain lifesaving medications that have been on the market for decades.
  • Antibiotics, Common Heartburn Drugs And Spread of Potentially Fatal Intestinal Infection
    (August 2015)
    Proton pump inhibitors, a widely used class of heartburn drugs, and essentially all antibiotics increase your risk of C. difficile infections, which can cause severe, even life-threatening diarrhea illness. Read this article to find out how to protect yourself from this dangerous infection.
  • Update: Treatment of Chronic Asthma
    (August 2015)
    Asthma is a common disease afflicting more than 16 million American adults and 6 million children. Find out the safest and most effective options for managing this chronic lung disease.
  • Questions & Answers for August 2015
    (August 2015)
    A reader asks whether a recent change in her thyroid disorder symptoms could have been caused by switching from a brand name to generic thyroid hormone replacement drug. See our advice regarding concerns about such thyroid medication changes.
  • Risks but No Benefits to Taking Newest Drugs For Type 2 Diabetes
    (August 2015)
    The airwaves are filled with ads promoting the newest class of diabetes medications, often referred to as “flozins.” In this article, we review the serious safety concerns that have prompted us to designate all flozins as Do Not Use.
  • Anticholinergics May Increase Dementia Risk in Elderly
    (August 2015)
    Learn about recent evidence suggesting that anticholinergic drugs — which include many antidepressants, antihistamines and overactive bladder control medications — may increase the risk for developing Alzheimer’s disease and other types of dementia in the elderly.

  View the entire July 2015 issue in PDF format

  • Public Citizen Shines a Light on Off-Label Promotion of Diabetes Drugs
    (July 2015)
    In a recent complaint to the FDA, we took several makers of diabetes drugs to task for direct-to-consumer ads that promote the drugs for unapproved uses. Find out the names of the drugs targeted in our complaint and the nature of the off-label uses being promoted in the ads.
  • New Study Reveals Many Patients at Risk for Dangerous Alcohol-Drug Interactions
    (July 2015)
    Recent research revealed that many patients consume alcohol while using drugs that may can cause dangerous side effects when combined with alcohol. Read this article to learn about the many ways alcohol can adversely interact with prescription and over-the-counter medications.
  • Industry Lawsuit Threatens FDA's Regulation of Drugs
    (July 2015)
    Worst Pills, Best Pills News editor Dr. Michael Carome discusses an unusual lawsuit filed by a drug company against the FDA that seeks to bypass the agency’s drug approval process and the prohibition against off-label promotion.
  • Eight Treatments Commonly Used for Osteoarthritis Pain
    (July 2015)
    Patients with osteoarthritis have many treatment options. Find out which ones are safest for relieving osteoarthritis pain.
  • News Brief for July 2015
    (July 2015)
    In this month’s news brief, we discuss Public Citizen’s recent petition to the FDA calling for a ban on all oral forms of a commonly used antifungal drug.

Additional Information from Public Citizen

Copyright © 2015 Public Citizen's Health Research Group. All rights reserved.